Among stroke patients treated with atorvastatin 80 mg, no significant differences have been observed either at 72 hours or 7 days after admissions with regard to serum levels of alanine transaminase, aspartate transaminase, gamma-glutamyltransferase, and alkaline phosphatase. This evidence concerns the gene GPT and stroke disorder.